1. Home
  2. QBTS vs VIR Comparison

QBTS vs VIR Comparison

Compare QBTS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$26.21

Market Cap

8.3B

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.78

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QBTS
VIR
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
773.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
QBTS
VIR
Price
$26.21
$6.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
11
Target Price
$30.08
$25.73
AVG Volume (30 Days)
31.6M
1.8M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,144,000.00
$16,860,000.00
Revenue This Year
$194.34
N/A
Revenue Next Year
$56.23
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
156.20
N/A
52 Week Low
$3.71
$4.16
52 Week High
$46.75
$14.45

Technical Indicators

Market Signals
Indicator
QBTS
VIR
Relative Strength Index (RSI) 49.19 61.51
Support Level $21.32 $6.49
Resistance Level $29.15 $6.89
Average True Range (ATR) 2.16 0.47
MACD 0.67 0.06
Stochastic Oscillator 64.83 83.17

Price Performance

Historical Comparison
QBTS
VIR

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: